Pharmac funds new cystic fibrosis medicine
New treatment for cystic fibrosis is on the horizon, one that will help young children suffering from the disorder digest their food more...
McGill spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus Junji...
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Stenotrophomonas maltophilia is one of the most common emerging multi-drug resistant organisms found in the lungs of people with cystic...
Inhaled Messenger RNA Treatment Fast-Tracked for Cystic Fibrosis
The Food and Drug Administration has granted Fast Track designation to MRT5005 (Translate Bio), an inhaled messenger RNA (mRNA)...
Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment
A new non-invasive tool, called XV technology, allows professionals to visualize airflow in a living lungs and could help in the...
New treatment kills off infection that can be deadly to cystic fibrosis patients
Credit: CC0 Public Domain A new treatment developed by researchers at Aston University and Birmingham Children's Hospital has been found...
SIMPLE TREATMENT OF TYPE 2 DIABETES WITH A LOW-CALORIE DIET IS SO EFFECTIVE THAT IT REVERSES THE DIS
A “revolutionary” treatment plan for type 2 diabetes has made the British National Health Service (NHS) very active as they position...
FDA Grants Orphan Drug Status to AR-501, Potential CF Treatment for Chronic Lung Infections
AR-501, an investigational inhaled formulation of gallium citrate to treat chronic lung infections in patients with cystic fibrosis (CF),...
FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations
The U.S. Food and Drug Administration (FDA) has approved Symdeko (tezacaftor/ivacaftor and ivacaftor) tablets for the treatment of...
Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month
May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and has been using gene therapy...
